Submitted:
12 May 2026
Posted:
13 May 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Background
2.1. Hantavirus Biology and Epidemiology
2.2. Phylogenetic Analysis
2.3. Host Immune Response to Hantavirus
2.4. Computational Approaches to Viral Infection Analysis
3. Materials and Methods
3.1. Gene Expression Data Acquisition and Processing
3.2. Pathway Enrichment Analysis
3.3. Protein–Protein Interaction Network Construction and Cen-Trality Analysis
- Degree centrality (CD): the fraction of nodes to which a given node is directly connected.
- Betweenness centrality (CB): the fraction of all shortest paths in the network that pass through a given node, normalised to [0,1].
- Closeness centrality (CC): the reciprocal of the average shortest path length from a given node to all other nodes.
3.4. Epidemiological Model
3.4.1. Model Structure
3.4.2. Model Equations
3.4.3. Basic Reproduction Number
3.4.4. Model Parameters
3.4.5. Strategies for Virus Spreading Containment 281 Four scenarios were simulated over a two-year period (730 days):
- Baseline: no intervention; all parameters at values in Table 1.
- Rodent population control: 50% reduction in the rodent birth rate (bR → 0.025 284 day−1), representing sustained rodent culling or habitat modification.
- Human exposure reduction: 75% reduction in the spillover transmission rate (βRH → 1×10−5 day−1), representing personal protective equipment (PPE), improved 287 housing, and rodent-proofing.
- Combined intervention: simultaneous application of scenarios 2 and 3.
3.4.6. Sensitivity Analysis
3.4.7. Numerical Implementation
3.5. Software and Reproducibility
4. Results
4.1. Phylogenetic Placement of the MV Hondius Outbreak Strain
4.2. Differential Gene Expression Analysis


4.3. Pathway Enrichment Analysis
4.4. PPI Network Centrality Analysis
4.5. Epidemiological Model Results
4.5.1. Baseline Dynamics
4.5.2. Intervention Scenarios
4.5.3. Sensitivity Analysis
5. Discussion
5.1. Molecular Landscape of Hantavirus Infection
5.2. Network Hubs as Candidate Therapeutic Targets
5.3. Epidemiological Implications
5.4. The MV Hondius Outbreak: A Real-World Stress Test of Model Assumptions
. 12 before isolation measures were enforced [10], a value that substantially exceeds the rodent-reservoir R0 = 1.452 estimated in our model. The Hondius setting – a confined vessel with shared air circulation, dining facilities, and close social contact among passengers – represents precisely the high-contact environment in which ANDV’s capacity for human-to-human spread is most likely to be realised [14]. Incorporating a human-to-human transmission term βHH · (IH/NH) · SH into equation (8) would transform the human compartment from a passive spillover sink into an active transmission chain, fundamentally altering the model’s intervention landscape: under such conditions, exposure reduction alone would be insufficient, and isolation of infectious individuals (reducing the effective βHH) would 517 become an equally critical intervention parameter.
. Taken together, the MV Hondius outbreak underscores that while the present model provides a valid and calibrated framework for the majority of hantavirus strains and transmission settings, ANDV demands a dedicated modelling extension that explicitly represents human-to-human transmission, spatial 534 dispersal, and strain-level genomic heterogeneity.5.5. Limitations
5.6. Future Directions
6. Conclusions
- HTNV infection of HUVECs induces a strong interferon-dominated transcriptional response, with MX2, CXCL10, CXCL11, DDX58, and OASL among the most strongly 572 upregulated genes, and concurrent suppression of ribosomal translation machinery.
- Network centrality analysis identifies ISG15, IRF1, CXCL10, STAT1, and DDX58 as the most central hubs in the hantavirus-responsive PPI network, representing 575 candidate targets for antiviral intervention and biomarker development.
- The coupled SEIRD epidemiological model (R0 = 1.452) demonstrates that han-tavirus can persist endemically in rodent populations and that human exposure reduction is substantially more effective than rodent population control alone for 579 reducing human disease burden.
- Rodent population control in isolation can paradoxically increase human cases through a dilution-like effect, highlighting the importance of combining rodent management with human exposure reduction measures.
Author Contributions
Data Availability
Acknowledgments
Conflicts of Interest
References
- [1] Pablo A Vial, Marcela Ferr´es, Cecilia Vial, Jonas Klingstro¨m, Clas Ahlm, Ren´e Lo´pez, Nicole Le Corre, and Gregory J Mertz. Hantavirus in humans: a review of clinical 607 aspects and management. The Lancet Infectious Diseases, 23(9):e371–e382, 2023.
- [2] Huaiyu Tian, Pengbo Yu, Bernard Cazelles, Lei Xu, Hua Tan, Juan Yang, ShanqianHuang, Bing Xu, Jun Cai, Chaofeng Ma, Jing Wei, Shenlong Li, Jiahui Qu, Mikael Laine, Jianpeng Wang, Shilu Tong, and Nils Chr. Stenseth. Interannual cycles ofHantaan virus outbreaks at the human–animal interface in central China are controlledby temperature and rainfall. Proceedings of the National Academy of Sciences, 114 613 (30):8041–8046, 2017. [CrossRef]
- [3] Fernando Tortosa, Fernando Perre, Celia Tognetti, Lucia Lossetti, Gabriela Carrasco,German Guaresti, Ayel´en Iglesias, Yesica Espasandin, and Ariel Izcovich. Seropreva-lence of hantavirus infection in non-epidemic settings over four decades: a systematic 617 review and meta-analysis. BMC Public Health, 24(1):2553, 2024.
- [4] Javier Toledo, Camila Balmaceda, Cecilia Vial, and Pablo A. Vial. Human-to-human 619 transmission of Andes virus: a systematic review. Journal of Infectious Diseases, 224 620 (Supplement 2):S285–S292, 2021. [CrossRef]
- [5] Daniele Fabbri, Monica Mirolo, Valentina Tagliapietra, Martin Ludlow, Albert Oster-haus, and Paola Beraldo. Ecological determinants driving orthohantavirus prevalencein small mammals of europe: a systematic review. One Health Outlook, 7(1):15, 2025.
- [6] Valeria P. Mart´ınez, Carla Bellomo, Jorge San Juan, Delia Pinna, Ricardo Forlenza,Mirta Elder, and Paula J. Padula. Person-to-person transmission of Andes virus. 626 Emerging Infectious Diseases, 11(12):1848–1853, 2005. [CrossRef]
- [7] Delia O. Alonso, Unai P´erez-Sautu, Carla M. Bellomo, Karina Prieto, Analia Iglesias,Roc´ıo Coelho, Natalia Periolo, and Valeria P. Mart´ınez. Person-to-person transmissionof Andes virus in hantavirus pulmonary syndrome, Argentina, 2014. Emerging Infectious Diseases, 26(4):792–796, 2020. [CrossRef]
- [8] Paula J. Padula, Alicia Edelstein, Silvia D. L. Miguel, Nora M. Lo´pez, Celia M. Rossi,and Ricardo D. Rabinovich. Hantavirus pulmonary syndrome outbreak in Argentina:molecular evidence for person-to-person transmission of Andes virus. Virology, 241 (2):323–330, 1998. [CrossRef]
- [9] Enrique Pizarro, Maritza Navarrete, Carolina Mendez, Luis Zaror, Carlos Mansilla,Mauricio Tapia, Cristian Carrasco, Paula Salazar, Roberto Murua, Paula Padula,Carola Otth, and Esteban Martin Rodr´ıguez. Immunocytochemical and ultrastructuralevidence supporting that Andes hantavirus (ANDV) is transmitted person-to-person 639 through the respiratory and/or salivary pathways. Frontiers in Microbiology, 10:2992, 640 2020. [CrossRef]
- [10] Valeria P. Mart´ınez, Nicholas Di Paola, Delia O. Alonso, Unai P´erez-Sautu, Carla M.Bellomo, Anal´ıa A. Iglesias, Roc´ıo M. Coelho, Natalia Periolo, Florencia Mart´ınez,Patricia A. Larson, Elyse R. Nagle, Joseph A. Chitty, Catherine B. Pratt, JorgeD´ıaz, Daniel M. Cisterna, Mart´ın C. Freire, Julio Leguizamo´n, Cristina N. Gardenal,Silvana C. Levis, Delia A. Enr´ıa, and Gustavo Palacios. “Super-spreaders” andperson-to-person transmission of Andes virus in Argentina. New England Journal of 647 Medicine, 383(23):2230–2241, 2020. [CrossRef]
- [11] Roc´ıo M. Coelho, Silvana Kehl, Natalia Periolo, Delia O. Alonso, Carla M. Bellomo,and Valeria P. Mart´ınez. Virological characterization of a new isolated strain ofAndes virus involved in the recent person-to-person transmission outbreak reported 651 in Argentina. PLOS Neglected Tropical Diseases, 19(2):e0013205, 2025. [CrossRef]
- [12] Carla M. Bellomo, Delia O. Alonso, Unai P´erez-Sautu, Anal´ıa Iglesias, Roc´ıo Coelho, Natalia Periolo, and Valeria P. Mart´ınez. Andes virus genome mutations that are likely associated with animal model attenuation and human person-to-person transmission. mSphere, 8(2):e00018–23, 2023. [CrossRef]
- [13] World Health Organization. Hantavirus cluster linked to cruise ship travel, multicountry — Disease Outbreak News DON599. Technical report, World Health Organization, May 2026. Published 5 May 2026. Available at: https://www.who. int/emergencies/disease-outbreak-news/item/2026-DON599 [Accessed 10 May 661 2026].
- [14] Public Health Agency of Canada. Rapid risk assessment: Hantavirus (Andes virus)outbreak on international cruise ship. Technical report, Public Health Agency ofCanada, May 2026. Assessment completed 8 May 2026. Available at: https://www.canada.ca/en/public-health/services/emergency-preparedness-response/rapid-risk-assessments-public-health-professionals/rapid-risk-assessment-hantavirus-andes-virus-outbreak-international-cruise-ship.html [Accessed 10 May 2026].
- [15] Hongwei Ma, Peng Han, Wei Ye, Hui Chen, Xuyang Zheng, Linfeng Cheng, LiangZhang, Lei Yu, Xingan Wu, Zhikai Xu, Fanglin Zhang, and Ying Zhu. The longnoncoding RNA NEAT1 exerts antihantaviral effects by acting as positive feedback for RIG-I signaling. Journal of Virology, 91(9):e02250–16, 2017. [CrossRef]
- [16] Angela D Luis, Richard J Douglass, James N Mills, and Ottar N Bjørnstad. Theeffect of seasonality, density and climate on the population dynamics of montana deer 676 mice, important reservoir hosts for sin nombre hantavirus. Journal of Animal Ecology, 79(2):462–470, 2010.
- [17] Asep K. Supriatna, Hennie Husniah, Edy Soewono, Bapan Ghosh, Usman Purwati,and Herlina Padjaitan. A mathematical model for the transmission of hantavirus 680 between rodents and humans. Computational and Mathematical Methods in Medicine, 681 2023:4349874, 2023. [CrossRef]
- [18] Juan Pablo Guti´errez-Jara, Mar´ıa Teresa Mun˜oz-Quezada, Fernando C´ordova-Lepe,and Ana Silva-Guzma´n. Mathematical model of the dynamics of hantavirus infectionin rodents and humans with the effect of rodent mobility. Pathogens, 12(2):220, 2023. [CrossRef]
- [19] Pietro Hiram Guzzi, Daniele Mercatelli, Carmine Ceraolo, and Federico M. Giorgi.Master regulator analysis of the SARS-CoV-2/Human interactome. Journal of Clinical 688 Medicine, 9(4):982, 2020. [CrossRef]
- [20] Annamaria Defilippo, Ugo Lomoio, Barbara Puccio, Pierangelo Veltri, and Pietro Hi-ram Guzzi. Exdiff: a modular and explainable framework combining network simula-tion and graph neural networks for diffusion modelling. Social Network Analysis and Mining, 16(1):3, 2026.
- [21] Francesco Branda, Mohamed Mustaf Ahmed, Annamaria Defilippo, Ugo Lomoio,Barbara Puccio, Massimo Ciccozzi, Fabio Scarpa, Pierangelo Veltri, and Pietro HiramGuzzi. Using graph models to understand West Nile virus epidemics: a computational 696 approach. F1000Research, 5:2813, 2016. [CrossRef]
- [22] Austin Royster, Songyang Ren, Saima Ali, Sheema Mir, and Mohammad Mir. Mod698 ulations in the host cell proteome by the hantavirus nucleocapsid protein. PLoS 699 Pathogens, 20(1):e1011925, 2024.
- [23] Yue Si, Haijun Zhang, Ziqing Zhou, Xudong Zhu, Yongheng Yang, He Liu, LiangZhang, Linfeng Cheng, Kerong Wang, Wei Ye, et al. Ripk3 promotes hantaviralreplication by restricting jak-stat signaling without triggering necroptosis. Virologica Sinica, 38(5):741–754, 2023.
- [24] Damian Szklarczyk, Rebecca Kirsch, Mikaela Koutrouli, Katerina Nastou, FarrokhMehryary, Radja Hachilif, Annika L. Gable, Tao Fang, Nadezhda T. Doncheva,Sampo Pyysalo, Lars J. Jensen, and Christian von Mering. STRING v11.5: protein–protein association networks with increased coverage supporting functional discovery 708 in genome-wide experimental datasets. Nucleic Acids Research, 51(D1):D638–D646, 709 2023. [CrossRef]
- [25] Maxim V Kuleshov, Matthew R Jones, Andrew D Rouillard, Nicolas F Fernandez,Qiaonan Duan, Zichen Wang, Simon Koplev, Sherry L Jenkins, Kathleen M Jagodnik,Alexander Lachmann, et al. Enrichr: a comprehensive gene set enrichment analysisweb server 2016 update. Nucleic acids research, 44(W1):W90–W97, 2016.
- [26] Phylo, Inc. Biomni: AI-powered scientific research platform. https://phylo.com, 715 2026. Accessed May 2026.
- [27] S. Lu, N. Zhu, W. Guo, X. Wang, K. Li, J. Yan, C. Jiang, S. Han, H. Xiang, X. Wu,Y. Liu, H. Xiong, L. Chen, Z. Gong, F. Luo, and W. Hou. Rna-seq revealed acircular rna-microrna-mrna regulatory network in hantaan virus infection. Frontiers 719 in Cellular and Infection Microbiology, 10:97, 2020. [CrossRef]
- [28] Christine A Clay, Erin M Lehmer, Stephen St Jeor, and M Denise Dearing. Sinnombre virus and rodent species diversity: a test of the dilution and amplification 722 hypotheses. PloS one, 4(7):e6467, 2009.
- [29] Peter T. Witkowski, Jan Felix Drexler, Ren´e Kallies, Martina Liˇckova´, Silvia Bokorova´,Gael D. Mananga, Toma´ˇs Szemes, Eric M. Leroy, Detlev H. Kru¨ger, Christian Drosten,and Boris Klempa. Phylogenetic analysis of a newfound bat-borne hantavirus supportsa laurasiatherian host association for ancestral hantaviruses. Infection, Genetics and 727 Evolution, 41:113–119, 2016. [CrossRef]
- [30] Won-Keun Kim, Seungchan Cho, Seung-Ho Lee, Jin Sun No, Geum-Young Lee,Kyungmin Park, Daesang Lee, Seong Tae Jeong, and Jin-Won Song. Genomicepidemiology and active surveillance to investigate outbreaks of hantaviruses. Frontiersin Cellular and Infection Microbiology, 10:532388, 2021.




| Parameter | Symbol | Value | Unit | Source |
|---|---|---|---|---|
|
Rodent parameters Birth rate |
bR | 0.050 | day−1 | [16] |
| Natural death rate | dR | 0.020 | day−1 | [16] |
| Disease-induced death rate | dR,I | 0.005 | day−1 | [16] |
| Direct transmission rate | βRR | 0.100 | day−1 | [17] |
| Environmental transmission | βenv | 0.040 | day−1 | [16] |
| Latency rate | σR | 1/7 | day−1 | [16] |
| Recovery rate | γR | 1/14 | day−1 | [16] |
| Carrying capacity | KR | 1,000 | individuals | [16] |
|
Human parameters Birth/death rate |
bH = dH | 1/(70 × 365) | day−1 | demographic |
| Spillover transmission rate | βRH | 4 × 10−5 | day−1 | calibrated [18] |
| Latency rate | σH | 1/14 | day−1 | [1] |
| Recovery rate | γH | 1/21 | day−1 | [1] |
| Disease-induced death rate | δH | 0.35/21 | day−1 | [1] |
| Human population size | NH | 10,000 | individuals | model assumption |
|
Derived quantities Basic reproduction number |
R0 | 1.452 | dimensionless | Eq. (12) |
| Mean rodent latent period | 1/σR | 7 | days | |
| Mean rodent infectious period | 1/(γR + dR + dR,I) | 11.9 | days | |
| Mean human incubation period | 1/σH | 14 | days | |
| Mean human infectious period | 1/(γH + δH) | 18.4 | days | |
| HCPS case fatality rate | CFR | 35% | % | [1] |
| Gene | log2FC | p-value | FDR | Direction |
|---|---|---|---|---|
| MX2 | 6.04 | 2.1 × 10−4 | 0.012 | UP |
| CXCL11 | 5.18 | 3.4 × 10−4 | 0.015 | UP |
| CXCL10 | 5.17 | 3.6 × 10−4 | 0.015 | UP |
| OASL | 4.86 | 4.1 × 10−4 | 0.016 | UP |
| CMPK2 | 4.73 | 4.8 × 10−4 | 0.017 | UP |
| EPSTI1 | 3.65 | 6.2 × 10−4 | 0.019 | UP |
| DDX58 | 3.51 | 7.1 × 10−4 | 0.020 | UP |
| TRIM22 | 2.14 | 1.1 × 10−3 | 0.026 | UP |
| BLZF1 | 2.08 | 1.3 × 10−3 | 0.028 | UP |
| TRIM38 | 1.92 | 1.8 × 10−3 | 0.035 | UP |
| EIF4B | -1.55 | 1.9 × 10−3 | 0.041 | DOWN |
| Gene | MRS | Degree | CB | CC | log2FC | FDR |
|---|---|---|---|---|---|---|
| ISG15 | 1.000 | 100 | 0.038 | 0.71 | 3.21 | 0.048 |
| IRF1 | 0.952 | 92 | 0.038 | 0.70 | 2.87 | 0.052 |
| CXCL10 | 0.901 | 86 | 0.039 | 0.69 | 5.17 | 0.015 |
| IFI35 | 0.878 | 96 | 0.034 | 0.68 | 2.43 | 0.061 |
| STAT1 | 0.887 | 114 | 0.023 | 0.72 | 2.31 | 0.063 |
| IFI44L | 0.821 | 88 | 0.031 | 0.67 | 3.44 | 0.044 |
| MX1 | 0.814 | 84 | 0.033 | 0.66 | 3.18 | 0.049 |
| GBP1 | 0.798 | 80 | 0.035 | 0.65 | 2.76 | 0.055 |
| ZC3HAV1 | 0.782 | 76 | 0.036 | 0.64 | 2.54 | 0.058 |
| TRIM25 | 0.771 | 74 | 0.034 | 0.63 | 2.21 | 0.067 |
| Scenario | Peak IR | Peak IH/100k | Cum. DH/10k | Attack rate (%) |
|---|---|---|---|---|
| Baseline | 26.1 | 10.00 | 2.98 | 0.119 |
| Rodent control | 16.7 | 10.00 | 3.15 | 0.125 |
| Exposure reduction | 26.1 | 2.50 | 0.94 | 0.037 |
| Combined | 16.7 | 2.50 | 0.98 | 0.039 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).